Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.46 CAD | -3.08% | -5.21% | +19.31% |
Apr. 22 | XORTX Therapeutics Announces Publication of Key Research in ADPKD in Peer-reviewed Journal | MT |
Apr. 22 | XORTX Announces Publication of Key Research in ADPKD | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.37M 5.98M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 3 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.92% |
1 day | -3.08% | ||
1 week | -5.21% | ||
Current month | -1.14% | ||
1 month | -24.95% | ||
3 months | +14.19% | ||
6 months | +1.17% | ||
Current year | +19.31% |
Managers | Title | Age | Since |
---|---|---|---|
Allen Davidoff
FOU | Founder | 64 | 18-01-08 |
Jim Fairbairn
DFI | Director of Finance/CFO | 65 | 18-11-05 |
Stephen Haworth
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul van Damme
BRD | Director/Board Member | - | 18-01-24 |
Allen Davidoff
FOU | Founder | 64 | 18-01-08 |
Chairman | 67 | 22-06-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 3.46 | -3.08% | 6,100 |
24-05-09 | 3.57 | -4.80% | 400 |
24-05-08 | 3.75 | +2.74% | 1,950 |
24-05-07 | 3.65 | +1.39% | 10,728 |
24-05-06 | 3.6 | -1.37% | 100 |
Delayed Quote Toronto S.E., May 10, 2024 at 03:59 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.31% | 7.34M | |
+3.91% | 109B | |
+10.87% | 105B | |
+0.12% | 22.25B | |
-13.14% | 22.09B | |
-7.89% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- XRTX Stock